rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0019134,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0205225,
umls-concept:C0205281,
umls-concept:C0206460,
umls-concept:C0679199,
umls-concept:C0702240,
umls-concept:C0948089,
umls-concept:C1273870,
umls-concept:C1274040,
umls-concept:C1283828,
umls-concept:C1551357
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-7-7
|
pubmed:abstractText |
Enoxaparin has demonstrated advantages over unfractionated heparin in low- to moderate-risk patients with non-ST-segment elevation acute coronary syndromes (ACS) treated with a conservative strategy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1538-3598
|
pubmed:author |
pubmed-author:AntmanElliott MEM,
pubmed-author:ArmstrongPaul WPW,
pubmed-author:AvezumAlvaroA,
pubmed-author:AylwardPhilP,
pubmed-author:BeckerRichard CRC,
pubmed-author:BiasucciLuigiL,
pubmed-author:BorzakStevenS,
pubmed-author:CaliffRobert MRM,
pubmed-author:CohenMarcM,
pubmed-author:ColJacquesJ,
pubmed-author:FergusonJames JJJ,
pubmed-author:FreyMarty JMJ,
pubmed-author:GoodmanShaunS,
pubmed-author:GrinesCindy LCL,
pubmed-author:GulbaDietrich CDC,
pubmed-author:GuneriSemaS,
pubmed-author:GurfinkelEnriqueE,
pubmed-author:HarringtonRobertR,
pubmed-author:HochmanJudith SJS,
pubmed-author:JALGG,
pubmed-author:KereiakesDean JDJ,
pubmed-author:KleimanNeal SNS,
pubmed-author:LangerAnatolyA,
pubmed-author:LeonMartin BMB,
pubmed-author:Lopez-SendonJose LuisJL,
pubmed-author:MahaffeyKenneth WKW,
pubmed-author:NesselChristopher CCC,
pubmed-author:PepineCarl JCJ,
pubmed-author:RuzylloWitoldW,
pubmed-author:SYNERGY Trial Investigators,
pubmed-author:SteinhublSteven RSR,
pubmed-author:TeirsteinPaul SPS,
pubmed-author:Toro-FigueroaLuisL,
pubmed-author:WhiteHarveyH
|
pubmed:issnType |
Electronic
|
pubmed:day |
7
|
pubmed:volume |
292
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
45-54
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15238590-Aged,
pubmed-meshheading:15238590-Angina Pectoris,
pubmed-meshheading:15238590-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15238590-Enoxaparin,
pubmed-meshheading:15238590-Female,
pubmed-meshheading:15238590-Fibrinolytic Agents,
pubmed-meshheading:15238590-Hemorrhage,
pubmed-meshheading:15238590-Heparin,
pubmed-meshheading:15238590-Humans,
pubmed-meshheading:15238590-Male,
pubmed-meshheading:15238590-Middle Aged,
pubmed-meshheading:15238590-Myocardial Infarction,
pubmed-meshheading:15238590-Stroke,
pubmed-meshheading:15238590-Survival Analysis,
pubmed-meshheading:15238590-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|